Kang Hong Lee1, Bo-Kyeong Kang2, Byung Kyu Ahn3. 1. Department of Surgery, Hanyang University College of Medicine, 222-1, Wangsimni-ro, Seongdong-gu, Seoul, 133-792, South Korea. 2. Department of Radiology, Hanyang University College of Medicine, Seoul, South Korea. 3. Department of Surgery, Hanyang University College of Medicine, 222-1, Wangsimni-ro, Seongdong-gu, Seoul, 133-792, South Korea. bkahn@hanyang.ac.kr.
Abstract
PURPOSE: Obesity is thought to influence postoperative complications and recurrence of mid and low rectal cancer (MLRC) because of intraoperative technical difficulties. However, few reports have described the relationship between obesity indices and the clinical outcomes of MLRC. This study aimed to investigate the association between visceral obesity on computed tomography (CT) and oncolofical outcomes after surgery for MLRC and identify the obesity index that most accurately reflects clinical outcomes. METHODS: We investigated 125 patients who underwent curative resection for MLRC between 2004 and 2010. Visceral fat area (VFA) was defined as the umbilicus-level intra-abdominal adipose tissue area measured by CT. Body mass index (BMI), total fat area, VFA, subcutaneous fat area (SFA) and VFA/SFA ratio (V/S ratio) were analysed. RESULTS: The median follow-up time was 60.3 months (range, 38.2-122.6 months). Recurrence was detected in 28 (22.4%) patients. Among the various obesity indices, recurrence was significantly associated with V/S ratio only (1.02 ± 0.45 versus 0.86 ± 0.34; P = 0.046). Stage, preoperative carcinoembryonic antigen level, V/S ratio, lymphatic invasion and perineural invasion were significantly associated with recurrence on univariate analysis, while only V/S ratio (P = 0.019; 95% confidence interval, 1.22 to 9.09) was significantly associated with recurrence on multivariate analysis. Disease-free and overall survival of the obese group (V/S ratio > 1.0) were shorter than those of the non-obese group. CONCLUSIONS: V/S ratio is the optimal obesity index for predicting stage I-III MLRC recurrence.
PURPOSE:Obesity is thought to influence postoperative complications and recurrence of mid and low rectal cancer (MLRC) because of intraoperative technical difficulties. However, few reports have described the relationship between obesity indices and the clinical outcomes of MLRC. This study aimed to investigate the association between visceral obesity on computed tomography (CT) and oncolofical outcomes after surgery for MLRC and identify the obesity index that most accurately reflects clinical outcomes. METHODS: We investigated 125 patients who underwent curative resection for MLRC between 2004 and 2010. Visceral fat area (VFA) was defined as the umbilicus-level intra-abdominal adipose tissue area measured by CT. Body mass index (BMI), total fat area, VFA, subcutaneous fat area (SFA) and VFA/SFA ratio (V/S ratio) were analysed. RESULTS: The median follow-up time was 60.3 months (range, 38.2-122.6 months). Recurrence was detected in 28 (22.4%) patients. Among the various obesity indices, recurrence was significantly associated with V/S ratio only (1.02 ± 0.45 versus 0.86 ± 0.34; P = 0.046). Stage, preoperative carcinoembryonic antigen level, V/S ratio, lymphatic invasion and perineural invasion were significantly associated with recurrence on univariate analysis, while only V/S ratio (P = 0.019; 95% confidence interval, 1.22 to 9.09) was significantly associated with recurrence on multivariate analysis. Disease-free and overall survival of the obese group (V/S ratio > 1.0) were shorter than those of the non-obese group. CONCLUSIONS: V/S ratio is the optimal obesity index for predicting stage I-III MLRC recurrence.
Entities:
Keywords:
Obesity; Rectal cancer; Visceral; Visceral fat area/subcutaneous fat area ratio
Authors: T Yoshizumi; T Nakamura; M Yamane; A H Islam; M Menju; K Yamasaki; T Arai; K Kotani; T Funahashi; S Yamashita; Y Matsuzawa Journal: Radiology Date: 1999-04 Impact factor: 11.105
Authors: Nikiforos Ballian; Meghan G Lubner; Alejandro Munoz; Bruce A Harms; Charles P Heise; Eugene F Foley; Gregory D Kennedy Journal: J Surg Oncol Date: 2011-07-12 Impact factor: 3.454
Authors: Frank A Sinicrope; Nathan R Foster; Daniel J Sargent; Michael J O'Connell; Cathryn Rankin Journal: Clin Cancer Res Date: 2010-03-09 Impact factor: 12.531
Authors: P Maurovich-Horvat; J Massaro; C S Fox; F Moselewski; C J O'Donnell; U Hoffmann Journal: Int J Obes (Lond) Date: 2006-09-05 Impact factor: 5.095
Authors: Whalen Clark; Erin M Siegel; Y Ann Chen; Xiuhua Zhao; Colin M Parsons; Jonathan M Hernandez; Jill Weber; Shalini Thareja; Junsung Choi; David Shibata Journal: J Am Coll Surg Date: 2013-03-21 Impact factor: 6.113
Authors: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna R Hollis; A David McCollum; Denise Brady; Michael J O'Connell; Robert J Mayer; Bernard Cummings; Christopher Willett; John S Macdonald; Al B Benson; Charles S Fuchs Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Nikiforos Ballian; Brett Yamane; Glen Leverson; Bruce Harms; Charles P Heise; Eugene F Foley; Gregory D Kennedy Journal: Ann Surg Oncol Date: 2010-01-15 Impact factor: 5.344
Authors: Wen Ching Chuang; Ngan Ming Tsang; Chi Cheng Chuang; Kai Ping Chang; Ping Ching Pai; Kuan Hung Chen; Wen Chi Chou; Shiao Fwu Tai; Shu Chen Liu; Kin Fong Lei Journal: PLoS One Date: 2020-01-30 Impact factor: 3.240
Authors: Domenic G Di Rollo; Josh McGovern; Christopher Morton; Gillian Miller; Ross Dolan; Paul G Horgan; Donald C McMillan; David Mansouri Journal: Scott Med J Date: 2022-05-22 Impact factor: 2.426